https://www.ndtvprofit.com/markets/citi-initiates-new-buy-on-eris-lifesciences-on-strong-sales-outlook?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Citi sees margin expansion of 500 basis points in Eris Lifesciences; Initiates coverage.